Cyclophosphamide in steroid refractory unclassifiable idiopathic interstitial pneumonia and interstitial pneumonia with autoimmune features (IPAF).
| Autor: | Wiertz IA; Interstitial Lung Diseases Center of Excellence, Dept of Pulmonology, St Antonius Hospital, Nieuwegein, The Netherlands., van Moorsel CHM; Interstitial Lung Diseases Center of Excellence, Dept of Pulmonology, St Antonius Hospital, Nieuwegein, The Netherlands.; Division of Heart and Lungs, University Medical Centre Utrecht, The Netherlands., Vorselaars ADM; Interstitial Lung Diseases Center of Excellence, Dept of Pulmonology, St Antonius Hospital, Nieuwegein, The Netherlands., Quanjel MJR; Interstitial Lung Diseases Center of Excellence, Dept of Pulmonology, St Antonius Hospital, Nieuwegein, The Netherlands., Grutters JC; Interstitial Lung Diseases Center of Excellence, Dept of Pulmonology, St Antonius Hospital, Nieuwegein, The Netherlands.; Division of Heart and Lungs, University Medical Centre Utrecht, The Netherlands. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | The European respiratory journal [Eur Respir J] 2018 Apr 19; Vol. 51 (4). Date of Electronic Publication: 2018 Apr 19 (Print Publication: 2018). |
| DOI: | 10.1183/13993003.02519-2017 |
| Abstrakt: | Competing Interests: Conflict of interest: I.A. Wiertz reports that this study is part of a research project (842002003) funded by ZonMw. He has received grants from Boehringer-Ingelheim (50% of travel payment to attend the WASOG 2015 international congress), outside the submitted work. Conflict of interest: J.C. Grutters reports grants from Boehringer-Ingelheim (two advisory board fees of <1000 EUR; and four 50% of travel payments to attend international congresses (ATS 2016, ATS 2015, WASOG 2015 and ATS 2014)), outside the submitted work. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|